Home › Skin Conditions › Indiana › Indianapolis
Skin Conditions clinical trials in Indianapolis, IN
4 studies for Skin Conditions are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
RecruitingPhase 3
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
RecruitingPhase 3
- The Indiana Clinical Trials Center, PC, Plainfield · 14 mi away
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
RecruitingPhase 3
- The Indiana Clinical Trials Center, PC, Plainfield · 14 mi away
About Skin Conditions
Your skin is your body's largest organ. It covers and protects your body. Learn about skin conditions, including causes, symptoms, and treatment.
More about Skin Conditions on MedlinePlus
Skin Conditions trials in other cities
- Phoenix, AZ4 studies
- Hollywood, FL4 studies
- Portland, OR4 studies
- Los Angeles, CA4 studies
- Boston, MA3 studies
- Arlington Heights, IL3 studies
- Saint Joseph, MO3 studies
- Minneapolis, MN3 studies
- Santa Clarita, CA3 studies
- New York City, NY3 studies
- Fargo, ND3 studies
- Tampa, FL3 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure23 studies
- Obesity20 studies
- Breast Cancer20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Cardiovascular Disease17 studies
- Lung Cancer16 studies
- Type 1 Diabetes14 studies
- Endometrial Cancer14 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.